Crystalline polymorphs of 1,6-dibromo-1,6-dideoxy-dulcitol
AssigneeEleison Pharmaceuticals LLC
InventorsStefano Luca Giaffreda, Elena Dichiarante
Life of this patent
Estimating the term…
Abstract
Described herein are polymorphic forms of 1,6-dibromo-1,6-dideoxy-dulcitol (dibromo dulcitol or DBD), which is a known antitumor agent. Also described are methods of making these new crystalline polymorphic forms as well as methods of using these polymorphic forms to treat cancer.
Claims31
A crystalline polymorph of 1,6-dibromo-1,6-dideoxy-dulcitol (DBD), wherein the crystalline polymorph exhibits an X-Ray Powder Diffraction Pattern substantially the same as the X-Ray Powder Diffraction Pattern shown in FIG. 1 and/or FIG. 2 and where said crystalline polymorph is formulated with at least one pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.